Effect of Montelukast Versus Co Enzyme in Sepsis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2023

Conditions
Sepsis
Interventions
DRUG

Montelukast Sodium 10 mg

Film coated tablets containing 10 mg montelukast

DRUG

Co-Enzyme Q10

Capsules contain 210 mg Co-Enzyme Q10

DRUG

Standard Treatment

Standard sepsis treatment includes fluid resuscitation, early administration of intravenous broad spectrum antibiotic (ceftriaxone 2gm/24 hour or meropenem 1g/8 hours, linezolid 600/12hours) till obtaining the microbiological culture to narrow the coverage, paracetamol intravenous antipyretic (paracetamol 1gm/8 hours) till no fever and temperature less than 380c, and prophylactic anticoagulant low molecular weight heparin (enoxaparin 40/24 hours), prophylactic stress ulcer (pantoprazole 40mg/24hours)

Trial Locations (1)

112311

Ghada El Adly, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER